Skip to main content

Fetal Tissue Research Restrictions Reversed

Officials in the US are removing restrictions on fetal tissue research that were added during the Trump Administration, the Associated Press reports.

The Trump Administration in 2019 halted intramural fetal tissue research at the National Institutes of Health, ended a contract with the University of California, San Francisco, that used fetal tissue for HIV research, and added an extra layer of ethical review for extramural research grants submitted to NIH using fetal tissue. ScienceInsider reported in August 2020 that the ethics board rejected nearly all the applications it reviewed.

Last week, the Washington Post reported that the Biden Administration was set to make changes these restrictions, following comments Health and Human Services Secretary Xavier Becerra made to lawmakers Thursday, though it was unclear what the changes would entail.

The AP now reports that the 2019 policy has been reversed and government researchers will again be able to conduct fetal tissue research and that outside researchers seeking fetal tissue research grants won't have to seek approval from an ethics board.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.